The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Hearing technology company Nuheara (NUH) has been awarded phase two works, worth $2 million, from U.S.-based, multinational IT company HP
  • It follows the completion of proof of concept for an earbud variant, details of which are confidential
  • The extension includes a purchase order for works associated with the development and engineering of the buds
  • Nuheara partnered with HP in August and commenced work on accompanying software services
  • Shares opened 1.9 per cent lower at 5.2 cents

Hearing technology company Nuheara (NUH) has been awarded phase two works under a collaboration agreement with HP, worth $2 million.

It follows the completion of a proof of concept for an earbud variant under development for the U.S.-based, multinational IT company, details of which are confidential.

The phase two extension includes a purchase order for works associated with the development and engineering of the buds.

CEO Justin Miller said the multi-staged partnership is a strong vote of confidence in the company’s technological innovation.

“This next stage of the HP collaboration agreement is the result of Nuheara’s globally recognised leadership in hearables innovation,” Justin stated.

“We are looking forward to deepening this strategic OEM [original equipment manufacturer] partnership over the coming months,” he added.

Nuheara partnered with HP in August and commenced work on accompanying software services.

Shares have been trading 1.9 per cent lower at 5.2 cents at 10:45 am AEDT.

NUH by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…